NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
235.05
Change Change %
1.35 0.58%

Updated:03 Jul, 2015, 15:58 PM IST

BSE
234.90
Change Change %
0.00 0.00%

Updated:03 Jul, 2015, 15:59 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

233.10 238.50

52 Wk Range

97.40 338.50
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

233.50238.50

52 Wk Range

97.75 338.50

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below

Suven Life Sciences's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 2,991.76
Earning Per Share (EPS TTM) (₹) 9.24
Price To Earnings (P/E) Ratio 25.44
Book Value Per Share (₹) 22.64
Price To Books (P/B) Ratio 10.38
EBIT Margin (%) 41.77
PAT Margin (%) 28.23
ROCE (%) 68.07
PAT Growth (%) 367.44
Total Debt to Equity (D/E) Ratio 0.34

More from Key Fundamentals »

Suven Life Sciences's Financial Summary

Parameter MAR'14
(₹ Cr.)
MAR'13
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 11.68 11.68 0.00%
Total Non-Current Liabilities 67.12 50.06 34.07%
Total Current Liabilities 155.06 107.39 44.39%
Total Liabilities 486.63 311.92 56.01%
Total Non-Current Assets 204.64 175.06 16.90%
Currents Investments 0.04 0.07 -48.88%
Cash and Bank 69.40 21.83 217.87%
Total Current Assets Excluding Current Investments 281.95 136.79 106.12%
Total Assets 486.63 311.92 56.01%
Profit and Loss:
Gross Sales 510.59 258.28 97.69%
Net Sales 510.31 257.88 97.88%
PBIDT (Excl OI) 219.06 53.19 311.88%
PAT 144.16 30.84 367.44%

More from Financial Summary �

Suven Life Sciences's Shareholding Pattern

Suven Life Sciences held by Mutual Fund Schemes

Scheme Holding(%)
No Records Found!

Post your comments about Suven Life Sciences